Enlivex ENLV
NASDAQ ENLV
$1.45 -0.05 (-3.33%)
As of: Aug 21, 2026 · 10:51 AM EDT

Enlivex (ENLV) Debt Ratio (2017 - 2023)

Enlivex (ENLV) posted quarterly Debt Ratio of 0.14 for Q2 2023, up 124.93% year-over-year from 0.06 in Q2 2022, and up 117.74% quarter-over-quarter from 0.06 in Q4 2022.

Enlivex (ENLV) Debt Ratio (2017 - 2023) Analysis & Trends

Enlivex's Debt Ratio history runs 7 years deep, the most recent figure standing at 0.14 for Q2 2023.

  • In Q2 2023, Debt Ratio rose 124.93% year-over-year to 0.14; the TTM figure through Jun 2023 stood at 0.14 (up 124.93% YoY), while the FY2022 annual figure was 0.06, up 9.47% from the prior year.
  • Debt Ratio for Q2 2023 stood at 0.14, up from 0.06 in the prior quarter.
  • The five-year high for Debt Ratio was 0.14 in Q2 2023, with the low at 0.0 in Q2 2019.
  • The 5-year median for Debt Ratio is 0.01 (2019), against an average of 0.03.
  • The sharpest annual moves came in 2019 and 2022: Debt Ratio tumbled 61.58% in 2019, then surged 1310.65% in 2022.
  • Enlivex's Debt Ratio stood at 0.02 in 2019, then decreased by 27.14% to 0.01 in 2020, then soared by 358.09% to 0.06 in 2021, then advanced by 9.47% to 0.06 in 2022, then soared by 117.74% to 0.14 in 2023.
  • Business Quant data shows ENLV's Debt Ratio at 0.14 in Q2 2023, 0.06 in Q4 2022, and 0.06 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.40 Bn 131.55 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.53 Bn 78.54 Bn 3.93 Bn 0.05
3 Argenx Se 65.20 Bn 60.02 Bn 1.37 Bn -
4 Moderna 60.40 Bn 55.26 Bn 52.00 Mn 0.05
5 BeOne Medicines 42.17 Bn 37.07 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.36 Bn 28.05 Bn 992.69 Mn -
7 BioNTech SE 28.74 Bn 10.34 Bn 668.28 Mn 0.03
8 Insmed 27.45 Bn 26.29 Bn 358.27 Mn 0.26
9 Royalty Pharma 27.17 Bn 26.33 Bn - 0.47
10 Enlivex 4.57 Mn -1.19 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 0.14
Dec 31, 2022 0.06
Jun 30, 2022 0.06
Dec 31, 2021 0.06
Jun 30, 2021 0.00
Dec 31, 2020 0.01
Dec 31, 2019 0.02
Sep 30, 2019 0.00
Jun 30, 2019 0.00
Mar 31, 2019 0.00
Dec 31, 2018 0.01
Sep 30, 2018 0.00
Dec 31, 2017 0.01